Target to $24 from $55
https://www.marketscreener.com/quote/stock/BIOXCEL-THERAPEUTICS-INC-41713826/news/Goldman-Sachs-Double-Downgrades-BioXcel-Therapeutics-to-Sell-From-Buy-Adjusts-Price-Target-to-24-F-37022246/
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.